Monthly Archives October 2018

Following on from information provided in 22 June 2017and 17 July 2017 we wish to advise that one further change will occur over the coming weeks. PHARMAC re-listed Pred Forte 1% 5 ml 1 April 2018 in order to cover the supply issue created at the time. Prednisolone AFT Eye Drops 1% 10 ml was initially on allocation and then…

Click here to read the PHARMAC DISPATCH dated 11 October 2018 relating to supply issues for the above mentioned products. Promethazine hydrochloride liquid 100 ml Note: - Phenergan Elixir will only be listed and fully funded until 30 November 2018 and STAT will apply. Ferrous sulphate tablets long-acting 325 mg Note: - STAT (three months all-at-once) will be removed from…

Click here to read the Pfizer notification relating to the supply of their Water for Injection 10 ml 50. Once again we ask that you continue to order the incumbent Pharmacode and ProPharma / PWR will automatically substitute on depletion of existing stock. On depletion of the temporary replacement we will revert back to the incumbent. Apologies for any inconvenience…

We have been advised of a supply issue relating to Acarbose tablets 100 mg as listed above. Click here to read Bayer notification. This is a short term supply issue. Having emailed PHARMAC to see if they were aware and if any alternative arrangements were being considered we advise the following:- Bayer are out of stock of Glucobay (acarbose) 100…

As advised via PHARMAC tender of 30 April 2018 there is to be a change in the listing and future sole supply. New listing from 1 November 2018 Dortimopt Eye Drops 2% with timolol 0.5% 5 ml OP                            Pharmacode 2398354         Schedule price $2.87 Incumbent brand Dortim-Actavis Eye Drops 2% with timolol 0.5% 5 ml OP             …

Click here to read the Mylan notification regarding upcoming changes to the appearance of Noflam Tab 250 gm and 500 mg. We thank you in anticipation of your ongoing support.

As many will be aware the price of the above product will reduce in the Pharmaceutical Schedule from 1 November 2018. Current schedule price $15.25 New schedule price $1.88 This was notified in the decision to award sole supply 29 June 2018. It was advised at the time that the supplier had chosen not to price support the supply chain…

As advised via PHARMAC tender of 30 April 2018 there is to be a change in the listing and future sole supply. New listing from 1 October 2018 without SA restrictions Solifenacin Mylan Tab 5 mg 30                                 Pharmacode 2546787             Schedule price $3.00 Solifenacin Mylan Tab 10 mg 30                               Pharmacode 2546795            Schedule price $5.50 Incumbent brand…

Click here to read the latest notification from Pfizer relating to the listing of Inspra Tab 50 mg from 1 October 2018. Inspra Tab 25 mg  were listed from 1 July 2018. This completes the listings that resulted from the Tenders Awarded 29 March 2018. We thank you in anticipation of your ongoing support.

Close